3-chloro-2'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-5-fluorobenzophenone, 97.0%, 1g

1-(2-NITROBENZYL)-4-METHYLPIPERAZINE, 95.0%, 5g

ETAMSYLATE, 95%, 5g

tert-Butyl (3R,5S)-6-hydroxy-3,5-O-isopropylidene-3,5-dihydroxyhexanoate, 95.0%, 25g

3-Cyclopropyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98%, 250mg

2-Bromo-4-hydroxybenzoic acid, 97%, 250mg

N-(3-Bromo-1-methyl-1H-indazol-5-yl)acetamide, 97%, 25g

3-CHLORO-1H-INDAZOLE-6-CARBOXYLIC ACID, 95%, 250mg

N-PROPYLACRYLAMIDE, 95.0%, 1g

3-Bromo-6-chloro-1-tetrahydropyran-2-yl-pyrazolo[4,3-c]pyridine, 98%, 500mg

iScope IS.1153-PLPHi Triokular mit Planphase-IOS-Objektiven und Rackless-Kreuztisch (unendlich)

tert-Butyl (2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethoxy)ethyl)carbamate, 95%, 100mg

N-(3-methoxybenzyl)-N-methylguanidine sulfate, 95.0%, 1g